This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (8)  • Contact me when this article is cited  Related Content  • Related letters  • Related articles  • Similar articles in this journal  Topic Collections  • Quality of Life  • Anemias  • Aging/ Geriatrics  • Alert me on articles by topic

Time for New Blood in Old Vessels?

Arch Intern Med. 2005;165:2187-2189.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

This issue of the ARCHIVES features 4 articles on anemia, 3 of which focus on its impact in the elderly and the fourth on its role in quality of life. The editorial decision to publish these articles as a group was timely and appropriate. In the United States, there are currently 35 000 000 people 65 years or older, of whom approximately 10% are anemic, and it is estimated that the number of elderly will double by the year 2030. Because the prevalence of anemia, like that of other hematologic disorders, increases with age,¹ substantial expansion of the oldest segment of our population has profound implications for public health and preventive and restorative medicine. Anemia, of course, can no longer be considered as merely a disease marker. Rather, it appears to have an independent deleterious influence on disease-related morbidity, mortality, and quality of life.² Furthermore, although blood transfusion is safer than . . . [Full Text of this Article]

WHAT HEMOGLOBIN LEVEL IS NORMAL IN THE ELDERLY?


IS RENAL ERYTHROPOIETIN PRODUCTION IMPAIRED IN THE HEALTHY ELDERLY?

WHAT ARE THE MAJOR CAUSES OF ANEMIA IN THE ELDERLY?

IS ANEMIA A MARKER OR MEDIATOR OF MORTALITY IN THE ELDERLY?

IS THERE A ROLE FOR PHARMACOLOGIC CORRECTION OF ANEMIA IN THE ELDERLY?

WHAT IS A SAFE LEVEL OF ANEMIA CORRECTION?

IS BLOOD THE FOUNTAIN OF YOUTH?

AUTHOR INFORMATION
Jerry L. Spivak, MD

RELATED LETTERS

Erythropoietin Resistance During Androgen Deficiency
Harry W. Daniell
Arch Intern Med. 2006;166(17):1923.
EXTRACT | FULL TEXT  

Erythropoietin Resistance During Androgen Deficiency—Reply
Jerry L. Spivak
Arch Intern Med. 2006;166(17):1923-1924.
EXTRACT | FULL TEXT  

RELATED ARTICLES

A Prospective Study of Anemia Status, Hemoglobin Concentration, and Mortality in an Elderly Cohort: The Cardiovascular Health Study
Neil A. Zakai, Ronit Katz, Calvin Hirsch, Michael G. Shlipak, Paulo H. M. Chaves, Anne B. Newman, and Mary Cushman
Arch Intern Med. 2005;165(19):2214-2220.
ABSTRACT | FULL TEXT  

Renal Function, Erythropoietin, and Anemia of Older Persons: The InCHIANTI Study
Alessandro Ble, Jeffrey C. Fink, Richard C. Woodman, Mark A. Klausner, B. Gwen Windham, Jack M. Guralnik, and Luigi Ferrucci
Arch Intern Med. 2005;165(19):2222-2227.
ABSTRACT | FULL TEXT  

The Impact of Anemia on Energy and Physical Functioning in Individuals With AIDS
Richard D. Semba, Barbara K. Martin, John H. Kempen, Jennifer E. Thorne, Albert W. Wu, and for the Studies of the Ocular Complications of AIDS Research Group
Arch Intern Med. 2005;165(19):2229-2236.
ABSTRACT | FULL TEXT  

Anemia and Outcomes in Patients With Heart Failure: A Study From the National Heart Care Project
Mikhail Kosiborod, Jeptha P. Curtis, Yongfei Wang, Grace L. Smith, Frederick A. Masoudi, JoAnne M. Foody, Edward P. Havranek, and Harlan M. Krumholz
Arch Intern Med. 2005;165(19):2237-2244.
ABSTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Iron Deficiency Anemia
Clark
Nutr Clin Pract 2008;23:128-141.
ABSTRACT | FULL TEXT  

Erythropoietin resistance during androgen deficiency.
Daniell
Arch Intern Med 2006;166:1923-1923.
FULL TEXT  

Impact of anemia on hospitalization and mortality in older adults
Culleton et al.
Blood 2006;107:3841-3846.
ABSTRACT | FULL TEXT